China hikes prices of key drug ingredients

While increased prices will put cost pressure on the domestic industry over the next few months, more importantly it has sparked speculation that this could be a potential ploy by China to scupper efforts of India’s drug industry to be self-reliant, or ‘Atmanirbhar’.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3ckhthg
via IFTTT